Mission Bio, the pioneer in high-throughput single-cell DNA and multi-omics analysis, has signed an agreement with Alliance Global (AGBL Group), distributors of biomedical technology and products.
Single-cell genomics developer Mission Bio has made three new hires to build out its executive team, following a $30 million series B round late last year and a new deal to provide sequencing services to LabCorp and its Covance drug development business.
Since launching at the end of 2017 with a focus on blood cancers, Mission Bio has built out its single-cell genomics platform to include custom offerings....